Abstract
We review the evidence supporting the role of glucocorticosteroids, trilazad, and GM1 ganglioside in spinal cord injury and provide our critique of the published studies, along with our recommendations for pharmacologic therapy for this complex and difficult problem.
Original language | English (US) |
---|---|
Pages (from-to) | 367-380 |
Number of pages | 14 |
Journal | Journal of spinal disorders |
Volume | 9 |
Issue number | 5 |
DOIs | |
State | Published - 1996 |
Keywords
- Glucocorticosteroids
- Pharmacotherapy
- Spinal cord
ASJC Scopus subject areas
- Surgery
- Clinical Neurology